Access the latest
U.S.Gov't Regulations

Advertising Regs
Amazon.com Master List

Audit Services

Biotech History
BPA Audit Services

Genetics 101

Publications: A-H
Publications: I- M
Publications: N- Z

Space Reservation

Tombstone Ads-National
Tombstone Ads- Regional
Trade Associations

Web Master List A-G
Web Master List H-N
Web Master List O-Z

Monday, September 18, 2000, 8:30 am Eastern Time

Company Press Release

SOURCE: Citation Clinical Labeling Systems

September 18, 2000 Farmingdale, NY,

Citation Clinical Labeling Systems recently announced the addition of the InfoPac®
Expanded Content Label (ECL) to their product line.

Since receiving their first label patent in 1993, Citation has delivered the latest in technology for their clinical trial customers. InfoPac® is the patented Expanded Content Label manufactured by Tursso Companies, Inc.

Faced with growing clinical trial expenses on the part of their customers, and the FDA constantly changing and increasing the amount of information required on clinical trial drugs, Citation found the solution with InfoPac®. 

A few of the features of this new product include:
-Up to forty-four pages of content
-Patented touch-and-seal (TM) closure
-Wide range of sizes and shapes available
-Booklet or Leaflet construction

Because Citation's InfoPac® labels are produced and supplied in roll form, they can be automatically applied, eliminating the need for secondary visual inspections required by the FDA for printed materials not supplied in roll form.

After some research Citation discovered there were as many packaging sizes are there are new drugs. Fortunately, InfoPac® offers Citation's customers a wide range of sizes and shapes. All available with either touch-and seal or tear-open for single-use applications. 

It's no secret to Citation or their customers, overseas clinical trials are increasing at a dramatic rate. InfoPac® reduces the chance of labeling mistakes by incorporating all the multi-lingual critical information on one InfoPac® label. 

Regarding the addition of InfoPac® to their product line, Richard Bolnick, President of Citation remarked, “We knew we had to offer our customers a solution to the growing problem of limited label space. Now with InfoPac® our customers can meet the challenges of the clinical trial business into next century with one less concern. We will continue to lead the industry by focusing on helping our customers find solutions to their clinical drug labeling problems”

About Citation Clinical Labeling Systems

Citation Clinical Labeling Systems is the technological leader in the development and distribution of specialty labels for the clinical trial industry. The labeling of clinical trial materials is a specialty branch of the drug and medical labeling business. The company currently holds two patents for, “Label Form for use in Drug Testing” and has an application for a third pending. Founded over thirty seven years ago, their client list includes more then half of the top ten pharmaceutical firms in the United States.

#######

SOURCE: Citation Clinical Labeling Systems

For more information and samples contact:
Citation Clinical Labeling Systems
125 Gazza Blvd
Farmingdale, N.Y. 11735
Tel: 631 293 4646
Fax: 631 293 4277
E-mail: Richb@clinicaltriallabels.com
Web site: www.clinicaltriallabels.com
 
 

In Europe Contact:

GP-Solutions (UK) Ltd Tel: 0161 743 8300 Fax: 0161 743 1755 E-mail: enquire@gp-packaging.com Web site: www.gp-packaging.com

###
End